Wishing you a productive and drama free day! Let God into your life. A day full of laughter and fulfillment in whatever it is that you do, topped off with a win for BAFANA BAFANA ❤️
@Zee_Mamzondi Ayikho lento oyishoyo. Ukuze kube Docket udinga case number, Case number iphuma mu register. So if it's not registered akulona docket lelo. Akuyona ne File coz nayo iba ne file number coz iya registwa .
The next witness in the #SenzoMeyiwaTrial could be a game changer. His testimony is expected to support claims that Ntanzi was kidnapped by the Cold Case Unit and unlawfully arrested, while also activating the defeating-the-ends-of-justice charges opened in KZN against Baloyi and Gininda.
If that evidence withstands scrutiny in court, Judge Ratha will face serious questions. The logical consequence would be to withdraw the charges and release Ntanzi, as the legitimacy of the entire arrest process would be placed under the spotlight.
JAŸ-Z responds to Drake's diss ‘The Jig Is Up’ off ‘ICEMAN’ in a new freestyle at the Roots Picnic in Philly 👀
"The jig is up, n**** I'm up 10, wrong chart champ, n****s looked up to Hov, I never looked up to them"
“A rapper can’t be my opp”
Talking to girls is so funny. You are 30 years old demanding princess treatment from me, a dude you met 3 minutes ago.
If you were such a princess you’d be married by now. 😂
Reading glasses might be done.
The FDA just approved a once-daily eye drop called VIZZ that sharpens near vision in about 30 minutes and keeps it sharp for up to 10 hours.
One drop. Each eye. Per day.
That's it.
The active ingredient is aceclidine, a compound first used back in 1975 to treat glaucoma. Scientists figured out it could be repurposed to gently shrink the pupil, creating a "pinhole effect" that pulls close-up text back into focus, the same trick your eye does when you squint.
Unlike Vuity, the 2021 drop that came before it, VIZZ doesn't mess with your focusing muscles. So no blurry distance vision. No brow ache. No weird zoom effect.
It was tested across more than 30,000 treatment days with no major complications.
Cost is roughly $2 a day.
This matters because presbyopia, the age-related slide that hits most people between 40 and 45, already affects more than 120 million Americans. By 2030, the World Health Organization expects around 2 billion people worldwide to have it.
LENZ Therapeutics, the maker, started rolling out samples in October.
The squint era is ending.
Source: Ynetnews, FOX 26 Houston, Yahoo News